KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Free Cash Flow (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Free Cash Flow for 13 consecutive years, with -$12.2 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow fell 708.37% to -$12.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$24.4 million through Dec 2025, down 165.01% year-over-year, with the annual reading at -$24.4 million for FY2025, 165.01% down from the prior year.
  • Free Cash Flow hit -$12.2 million in Q4 2025 for ClearPoint Neuro, down from -$3.3 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$1.2 million in Q4 2023 to a low of -$12.2 million in Q4 2025.
  • Historically, Free Cash Flow has averaged -$3.9 million across 5 years, with a median of -$3.5 million in 2021.
  • Biggest five-year swings in Free Cash Flow: surged 61.66% in 2023 and later crashed 708.37% in 2025.
  • Year by year, Free Cash Flow stood at -$3.6 million in 2021, then grew by 13.54% to -$3.1 million in 2022, then soared by 61.66% to -$1.2 million in 2023, then dropped by 26.55% to -$1.5 million in 2024, then crashed by 708.37% to -$12.2 million in 2025.
  • Business Quant data shows Free Cash Flow for CLPT at -$12.2 million in Q4 2025, -$3.3 million in Q3 2025, and -$2.6 million in Q2 2025.